Point of care tobacco treatment sustains during COVID-19, a global pandemic.
Cancer Epidemiol
; 78: 102005, 2022 06.
Article
in English
| MEDLINE | ID: covidwho-1889256
ABSTRACT
BACKGROUND:
Tobacco cessation treatment for cancer patients is essential to providing comprehensive oncologic care. We have implemented a point of care tobacco treatment care model enabled by electronic health record (EHR) modifications in a comprehensive cancer center. Data are needed on the sustainability of both reach of treatment and effectiveness over time, including the COVID-19 pandemic.METHODS:
Using EHR data from the pre-implementation (P 5 months) and post-implementation periods (6 month-blocks, T1-T5 for a total of 30 months), we compared two primaryoutcomes:
1) reach of treatment among those smoking and 2) effectiveness assessed by smoking cessation among those smoking in the subsequent 6 month period. We analyzed the data using generalized estimation equation regression models.RESULTS:
With the point of care tobacco treatment care model, reach of treatment increased from pre to post T5 (3.2 % vs. 48.4 %, RR 15.50, 95 % CI 10.56-22.74, p < 0.0001). Reach of treatment in all post periods (T1-T5 including the COVID-19 pandemic time) remained significantly higher than the pre period. Effectiveness, defined by smoking cessation among those smoking, increased from pre to post T2 before the pandemic (12.4 % vs. 21.4 %, RR 1.57, 95 % CI 1.31-1.87, p < 0.0001). However, effectiveness, while higher in later post periods (T3, T4), was no longer significantly increased compared with the pre period.CONCLUSION:
A point of care EHR-enabled tobacco treatment care model demonstrates sustained reach up to 30 months following implementation, even during the COVID-19 pandemic and changes in healthcare prioritization. Effectiveness was sustained for 12 months, but did not sustain through the subsequent 12 months.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Smoking Cessation
/
COVID-19
Type of study:
Experimental Studies
/
Observational study
Limits:
Humans
Language:
English
Journal:
Cancer Epidemiol
Journal subject:
Epidemiology
/
Neoplasms
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS